6-(6,7-二氢-7-羟基-5H-吡咯并[1,2-c]咪唑-7-基)-n-甲基-2-萘羧酰胺结构式
|
常用名 | 6-(6,7-二氢-7-羟基-5H-吡咯并[1,2-c]咪唑-7-基)-n-甲基-2-萘羧酰胺 | 英文名 | TAK-700 (Orteronel) |
---|---|---|---|---|
CAS号 | 426219-18-3 | 分子量 | 307.346 | |
密度 | 1.4±0.1 g/cm3 | 沸点 | 685.1±45.0 °C at 760 mmHg | |
分子式 | C18H17N3O2 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 368.2±28.7 °C |
用途Orteronel (racemic) is a mixture of S-Orteronel and R-Orteronel isomers. Orteronel, aslo known as TAK-700, is an orally bioavailable non-steroidal androgen synthesis inhibitor of steroid 17alpha-monooxygenase (17,20 lyase) with potential antiandrogen activity. TAK-700 binds to and inhibits the steroid 17alpha-monooxygenase in both the testes and adrenal glands, thereby inhibiting androgen production. This may decrease androgen-dependent growth signaling and may inhibit cell proliferation of androgen-dependent tumor cells. |
中文名 | 6-(6,7-二氢-7-羟基-5H-吡咯并[1,2-c]咪唑-7-基)-n-甲基-2-萘羧酰胺 |
---|---|
英文名 | 6-(7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl)-N-methylnaphthalene-2-carboxamide |
英文别名 | 更多 |
密度 | 1.4±0.1 g/cm3 |
---|---|
沸点 | 685.1±45.0 °C at 760 mmHg |
分子式 | C18H17N3O2 |
分子量 | 307.346 |
闪点 | 368.2±28.7 °C |
精确质量 | 307.132080 |
PSA | 67.15000 |
LogP | -0.13 |
外观性状 | 粉末 |
蒸汽压 | 0.0±2.2 mmHg at 25°C |
折射率 | 1.695 |
储存条件 | -20℃ |
上游产品 9 | |
---|---|
下游产品 2 | |
6-(7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide |
S1195_Selleck |
2-Naphthalenecarboxamide, 6-(6,7-dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl- |
TAK700 |
(S)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-e]imidazol-7-yl)-N-methyl-2-naphthamide |
TAK-700 (Orteronel) |
6-[7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthamide |
Orteronel |
TAK-700 |